Results of a phase II multicenter trial of pentostatin and rituximab in patients with low grade B-cell non-Hodgkin's lymphoma: an effective and minimally toxic regimen.
暂无分享,去创建一个
L. Asmar | E. Harden | W. Hyman | K. Boehm | N. D. Di Bella | D. Faragher | C. Matei | R. Drapkin | Mae Y Mirabel